ZFP37
gene geneOn this page
Also known as ZNF906
Summary
ZFP37 (ZFP37 zinc finger protein, HGNC:12863) is a protein-coding gene on chromosome 9q32, encoding Zinc finger protein 37 homolog (Q9Y6Q3). May be involved in transcriptional regulation.
This gene encodes a transcription factor that belongs to a large family of zinc finger proteins. A similar protein in mouse is thought to play a role in regulating the structures of the nucleolus and centromere in neurons. Alternate splicing results in multiple transcript variants.
Source: NCBI Gene 7539 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 81 total
- MANE Select transcript:
NM_003408
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:12863 |
| Approved symbol | ZFP37 |
| Name | ZFP37 zinc finger protein |
| Location | 9q32 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | ZNF906 |
| Ensembl gene | ENSG00000136866 |
| Ensembl biotype | protein_coding |
| OMIM | 602951 |
| Entrez | 7539 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 5 protein_coding
ENST00000374227, ENST00000553380, ENST00000555206, ENST00000940564, ENST00000948256
RefSeq mRNA: 3 — MANE Select: NM_003408
NM_001282515, NM_001282518, NM_003408
CCDS: CCDS65109, CCDS65110, CCDS6787
Canonical transcript exons
ENST00000374227 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000806242 | 113049362 | 113049496 |
| ENSE00001317422 | 113049791 | 113049872 |
| ENSE00001462839 | 113038377 | 113044268 |
| ENSE00001462841 | 113056557 | 113056724 |
Expression profiles
Bgee: expression breadth ubiquitous, 187 present calls, max score 84.93.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.9401 / max 108.5483, expressed in 1151 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 102078 | 3.6594 | 1109 |
| 102079 | 0.2807 | 133 |
Top tissues by expression
269 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cortical plate | UBERON:0005343 | 84.93 | gold quality |
| ganglionic eminence | UBERON:0004023 | 81.77 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.83 | gold quality |
| ventricular zone | UBERON:0003053 | 78.58 | gold quality |
| calcaneal tendon | UBERON:0003701 | 76.86 | gold quality |
| islet of Langerhans | UBERON:0000006 | 75.23 | gold quality |
| embryo | UBERON:0000922 | 73.35 | gold quality |
| stromal cell of endometrium | CL:0002255 | 73.06 | gold quality |
| left ovary | UBERON:0002119 | 72.50 | gold quality |
| right ovary | UBERON:0002118 | 72.29 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 71.59 | gold quality |
| cerebellar cortex | UBERON:0002129 | 71.55 | gold quality |
| ovary | UBERON:0000992 | 71.36 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 71.21 | gold quality |
| body of uterus | UBERON:0009853 | 70.33 | gold quality |
| cerebellum | UBERON:0002037 | 70.28 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 69.82 | gold quality |
| right coronary artery | UBERON:0001625 | 68.56 | gold quality |
| mucosa of stomach | UBERON:0001199 | 68.45 | gold quality |
| endocervix | UBERON:0000458 | 68.44 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 68.17 | gold quality |
| pituitary gland | UBERON:0000007 | 67.99 | gold quality |
| left coronary artery | UBERON:0001626 | 67.66 | gold quality |
| adenohypophysis | UBERON:0002196 | 67.64 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 67.57 | gold quality |
| popliteal artery | UBERON:0002250 | 67.56 | gold quality |
| tibial artery | UBERON:0007610 | 67.56 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 67.53 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 67.52 | gold quality |
| prefrontal cortex | UBERON:0000451 | 67.48 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 3.59 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): TP53
miRNA regulators (miRDB)
48 targeting ZFP37, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-4668-3P | 100.00 | 68.74 | 2635 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-4789-3P | 99.99 | 70.75 | 2484 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-3065-5P | 99.97 | 71.56 | 3281 |
| HSA-MIR-9-3P | 99.96 | 70.88 | 2068 |
| HSA-LET-7C-3P | 99.95 | 73.42 | 2862 |
| HSA-MIR-381-3P | 99.93 | 71.87 | 2854 |
| HSA-MIR-3143 | 99.93 | 71.96 | 3104 |
| HSA-MIR-300 | 99.92 | 71.76 | 2856 |
| HSA-MIR-374A-5P | 99.90 | 71.34 | 2923 |
| HSA-MIR-374B-5P | 99.90 | 69.98 | 2734 |
| HSA-MIR-3671 | 99.90 | 73.04 | 3897 |
| HSA-MIR-369-3P | 99.85 | 70.52 | 2264 |
| HSA-MIR-448 | 99.79 | 72.37 | 2103 |
| HSA-MIR-4524A-3P | 99.72 | 66.85 | 2406 |
| HSA-MIR-4729 | 99.69 | 72.18 | 4233 |
| HSA-MIR-466 | 99.67 | 70.85 | 2863 |
| HSA-MIR-586 | 99.65 | 70.40 | 2051 |
| HSA-MIR-7152-5P | 99.60 | 69.33 | 2094 |
| HSA-MIR-4310 | 99.59 | 68.84 | 2527 |
| HSA-MIR-7159-5P | 99.53 | 72.12 | 2472 |
| HSA-MIR-6832-3P | 99.52 | 70.44 | 1726 |
| HSA-MIR-5689 | 99.50 | 71.26 | 1154 |
| HSA-MIR-136-5P | 99.50 | 67.26 | 1153 |
| HSA-MIR-4666A-5P | 99.41 | 69.72 | 1887 |
Cross-species orthologs
7 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp37 | ENSMUSG00000028389 |
| rattus_norvegicus | Zfp37-ps1 | ENSRNOG00000046629 |
| rattus_norvegicus | AABR07048473.1 | ENSRNOG00000051164 |
| rattus_norvegicus | Zfp37 | ENSRNOG00000069865 |
| drosophila_melanogaster | CG2712 | FBGN0024975 |
| drosophila_melanogaster | Phs | FBGN0036522 |
| drosophila_melanogaster | CG3281 | FBGN0260741 |
Paralogs (62): ZNF582 (ENSG00000018869), ZNF264 (ENSG00000083844), ZNF343 (ENSG00000088876), ZNF684 (ENSG00000117010), ZNF133 (ENSG00000125846), ZNF557 (ENSG00000130544), ZNF337 (ENSG00000130684), ZNF20 (ENSG00000132010), ZNF614 (ENSG00000142556), KRBOX4 (ENSG00000147121), ZNF599 (ENSG00000153896), ZNF19 (ENSG00000157429), ZNF589 (ENSG00000164048), PRDM9 (ENSG00000164256), ZNF180 (ENSG00000167384), ZNF558 (ENSG00000167785), ZNF35 (ENSG00000169981), ZNF778 (ENSG00000170100), ZNF439 (ENSG00000171291), ZNF440 (ENSG00000171295), ZNF556 (ENSG00000172000), ZNF554 (ENSG00000172006), ZNF596 (ENSG00000172748), ZNF80 (ENSG00000174255), ZNF266 (ENSG00000174652), ZNF25 (ENSG00000175395), ZNF77 (ENSG00000175691), ZNF169 (ENSG00000175787), ZNF404 (ENSG00000176222), ZNF491 (ENSG00000177599), ZNF620 (ENSG00000177842), ZNF619 (ENSG00000177873), ZNF875 (ENSG00000181666), ZNF329 (ENSG00000181894), ZFP90 (ENSG00000184939), ZNF566 (ENSG00000186017), ZNF529 (ENSG00000186020), ZNF749 (ENSG00000186230), ZNF555 (ENSG00000186300), ZNF70 (ENSG00000187792)
Protein
Protein identifiers
Zinc finger protein 37 homolog — Q9Y6Q3 (reviewed: Q9Y6Q3)
All UniProt accessions (1): Q9Y6Q3
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Tissue specificity. Expressed at low level in several tissues including fetal cartilage.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9Y6Q3-1 | 1 | yes |
| Q9Y6Q3-2 | 2 | |
| Q9Y6Q3-3 | 3 |
RefSeq proteins (3): NP_001269444, NP_001269447, NP_003399* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050826 | Krueppel_C2H2_ZnFinger | Family |
| IPR056436 | Znf-C2H2_ZIC1-5/GLI1-3-like | Domain |
Pfam: PF00096, PF01352, PF23561
UniProt features (32 total): zinc finger region 12, compositionally biased region 7, sequence conflict 4, region of interest 3, splice variant 2, chain 1, domain 1, modified residue 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9Y6Q3-F1 | 67.54 | 0.45 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 42
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 80 (showing top):
GGGNRMNNYCAT_UNKNOWN, YY1_Q6, SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5, MARTINEZ_RB1_TARGETS_DN, SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2, YY1_02, MARTINEZ_RB1_AND_TP53_TARGETS_UP, GCCATNTTG_YY1_Q6, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS, RAO_BOUND_BY_SALL4_ISOFORM_B, RELA_DN.V1_UP, NOTCH_DN.V1_DN, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, E2F5_TARGET_GENES
GO Biological Process (3): regulation of DNA-templated transcription (GO:0006355), regulation of transcription by RNA polymerase II (GO:0006357), negative regulation of DNA-templated transcription (GO:0045892)
GO Molecular Function (6): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), DNA-binding transcription factor activity (GO:0003700), zinc ion binding (GO:0008270), DNA binding (GO:0003677), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 3 |
| DNA-templated transcription | 2 |
| transcription cis-regulatory region binding | 2 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| transcription by RNA polymerase II | 1 |
| negative regulation of RNA biosynthetic process | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transcription regulator activity | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
472 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZFP37 | ZPR1 | O75312 | 736 |
| ZFP37 | FHIT | P49789 | 661 |
| ZFP37 | SLC46A2 | Q9BY10 | 617 |
| ZFP37 | SF3B4 | Q15427 | 548 |
| ZFP37 | LMO2 | P25791 | 478 |
| ZFP37 | SLC31A2 | O15432 | 478 |
| ZFP37 | TAF11 | Q15544 | 461 |
| ZFP37 | TAF9B | Q9HBM6 | 459 |
| ZFP37 | PBX1 | P40424 | 447 |
| ZFP37 | PCDH17 | O14917 | 427 |
| ZFP37 | C4orf33 | Q8N1A6 | 418 |
| ZFP37 | BASP1 | P80723 | 410 |
| ZFP37 | RUNX1T1 | Q06455 | 397 |
| ZFP37 | CDH18 | Q13634 | 387 |
| ZFP37 | MAGEA11 | P43364 | 369 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZFP37 | CANX | psi-mi:“MI:0915”(physical association) | 0.400 |
| ZFP37 | ECE1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| WDR46 | NKRF | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (6): ZFP37 (Affinity Capture-MS), ZFP37 (Affinity Capture-MS), ZFP37 (Proximity Label-MS), ZFP37 (Affinity Capture-MS), ZFP37 (Affinity Capture-MS), ZFP37 (Affinity Capture-MS)
ESM2 similar proteins: A0A087WUV0, A0JNB1, A2VDP4, B2RUI1, P0CG31, P10072, P17025, P17036, P17097, P18733, P51814, Q08ER8, Q09FC8, Q0VGE8, Q14590, Q15937, Q16600, Q2M3X9, Q4V8A8, Q5CZA5, Q5R8G9, Q5RBX0, Q5VIY5, Q68DI1, Q6J6I6, Q6NX49, Q6P1L6, Q6PG37, Q6ZMS4, Q6ZMW2, Q80YP6, Q86UD4, Q86Y25, Q8IZ26, Q8N184, Q8NB42, Q8NEK5, Q8TAF7, Q8TF47, Q8WXB4
Diamond homologs: A6NFI3, A6NM28, A6NNF4, A6QLU5, A8MQ14, A8MUV8, B4DU55, B4DX44, E9Q8G5, O60290, O75290, O75467, O94892, O95780, P0DPD5, P17014, P17031, P17032, P17097, P17098, P21506, P51523, P59923, Q02525, Q03936, Q05481, Q06732, Q08DG8, Q14586, Q14590, Q15928, Q16587, Q2M218, Q2TL60, Q3B7M4, Q3KQV3, Q3SXZ3, Q49AA0, Q4R6C2, Q4R8H9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
81 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 70 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
650 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:113049363:T:TA | donor_gain | 1.0000 |
| 9:113056555:A:AC | donor_gain | 1.0000 |
| 9:113056556:C:CC | donor_gain | 1.0000 |
| 9:113049360:A:AC | donor_gain | 0.9900 |
| 9:113049360:ACTT:A | donor_gain | 0.9900 |
| 9:113049361:C:CC | donor_gain | 0.9900 |
| 9:113049361:CTT:C | donor_gain | 0.9900 |
| 9:113049361:CTTC:C | donor_gain | 0.9900 |
| 9:113049493:CACC:C | acceptor_gain | 0.9900 |
| 9:113049495:CC:C | acceptor_gain | 0.9900 |
| 9:113049496:CC:C | acceptor_gain | 0.9900 |
| 9:113056534:C:CA | donor_gain | 0.9900 |
| 9:113056547:CAG:C | donor_gain | 0.9900 |
| 9:113056552:CTCAC:C | donor_loss | 0.9900 |
| 9:113056554:C:CG | donor_loss | 0.9900 |
| 9:113056555:ACC:A | donor_loss | 0.9900 |
| 9:113056556:CCG:C | donor_gain | 0.9900 |
| 9:113056556:CCGC:C | donor_loss | 0.9900 |
| 9:113044266:CTT:C | acceptor_gain | 0.9800 |
| 9:113049354:CAACT:C | donor_loss | 0.9800 |
| 9:113049355:AACTT:A | donor_loss | 0.9800 |
| 9:113049356:ACTTA:A | donor_loss | 0.9800 |
| 9:113049357:CTTAC:C | donor_loss | 0.9800 |
| 9:113049358:T:TA | donor_loss | 0.9800 |
| 9:113049359:T:TC | donor_loss | 0.9800 |
| 9:113049360:A:C | donor_loss | 0.9800 |
| 9:113049361:C:CT | donor_loss | 0.9800 |
| 9:113049361:CT:C | donor_gain | 0.9800 |
| 9:113049364:C:A | donor_gain | 0.9800 |
| 9:113049497:C:CC | acceptor_gain | 0.9800 |
AlphaMissense
4214 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:113042872:A:C | F582L | 0.999 |
| 9:113042872:A:T | F582L | 0.999 |
| 9:113042874:A:G | F582L | 0.999 |
| 9:113042956:A:C | F554L | 0.999 |
| 9:113042956:A:T | F554L | 0.999 |
| 9:113042958:A:G | F554L | 0.999 |
| 9:113043124:A:C | F498L | 0.999 |
| 9:113043124:A:T | F498L | 0.999 |
| 9:113043126:A:G | F498L | 0.999 |
| 9:113042788:G:C | F610L | 0.998 |
| 9:113042788:G:T | F610L | 0.998 |
| 9:113042790:A:G | F610L | 0.998 |
| 9:113042840:C:G | R593P | 0.998 |
| 9:113042939:A:G | L560P | 0.998 |
| 9:113043208:G:C | F470L | 0.998 |
| 9:113043208:G:T | F470L | 0.998 |
| 9:113043210:A:G | F470L | 0.998 |
| 9:113043376:A:C | F414L | 0.998 |
| 9:113043376:A:T | F414L | 0.998 |
| 9:113043378:A:G | F414L | 0.998 |
| 9:113043460:G:C | F386L | 0.998 |
| 9:113043460:G:T | F386L | 0.998 |
| 9:113043462:A:G | F386L | 0.998 |
| 9:113043628:A:C | F330L | 0.998 |
| 9:113043628:A:T | F330L | 0.998 |
| 9:113043630:A:G | F330L | 0.998 |
| 9:113042843:T:G | Q592P | 0.997 |
| 9:113042855:A:G | L588P | 0.997 |
| 9:113043040:A:C | F526L | 0.997 |
| 9:113043040:A:T | F526L | 0.997 |
dbSNP variants (sampled 300 via entrez): RS1000003441 (9:113038210 A>G), RS1000046363 (9:113045320 A>T), RS1000062362 (9:113038415 C>T), RS1000109458 (9:113055097 G>A), RS1000124039 (9:113039998 T>A,C), RS1000313089 (9:113045382 T>A,C), RS1000326493 (9:113052505 A>G,T), RS1000366088 (9:113038729 G>A), RS1000439671 (9:113038064 A>C), RS1000473270 (9:113058539 T>C,G), RS1000782545 (9:113051768 A>G), RS1000808301 (9:113057824 C>T), RS1000866453 (9:113058507 T>C), RS1001062516 (9:113050929 G>A), RS1001200619 (9:113037884 G>C)
Disease associations
OMIM: gene MIM:602951 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002931_15 | Aluminium levels | 6.000000e-06 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
29 total (human), top 29 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, decreases expression | 4 |
| sodium arsenite | decreases expression, increases abundance, increases expression | 3 |
| trichostatin A | affects cotreatment, decreases expression | 2 |
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 2 |
| urushiol | decreases expression | 1 |
| testosterone enanthate | affects expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | affects cotreatment, decreases methylation | 1 |
| beta-lapachone | decreases expression, increases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| abrine | increases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| jinfukang | decreases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| 2,3,5-trichloro-6-phenyl-(1,4)benzoquinone | increases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Fulvestrant | affects cotreatment, decreases methylation | 1 |
| Acetaldehyde | increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Arsenic | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | affects methylation, decreases methylation | 1 |
| Cisplatin | decreases expression | 1 |
| Quercetin | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Urethane | increases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Copper Sulfate | increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_XV96 | HEK293 eGFP-ZFP37 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.